MedPath

JAPAN CLINICAL ONCOLOGY GROUP

🇯🇵Japan
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

15

Active:0
Completed:11

Trial Phases

2 Phases

Phase 2:3
Phase 3:12

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (15 trials with phase data)• Click on a phase to view related trials

Phase 3
12 (80.0%)
Phase 2
3 (20.0%)

Elderly NSCLC/D vs DP (JCOG0207)

Phase 3
Terminated
Conditions
Non-small-cell Lung Cancer
First Posted Date
2005-09-19
Last Posted Date
2016-09-12
Lead Sponsor
Japan Clinical Oncology Group
Target Recruit Count
230
Registration Number
NCT00190476
Locations
🇯🇵

Aichi Cancer Center Hospital, Nagoya,Chikusa-ku,Kanokoden,1-1, Aichi, Japan

🇯🇵

Aichi Cancer Center,Aichi Hospital, Okazaki,Kake-machi,Kuriyado,18, Aichi, Japan

🇯🇵

National Cancer Center Hospital East, Kashiwa,Kashiwanoha,6-5-1, Chiba, Japan

and more 26 locations

A Trial of Doxorubicin/Cyclophosphamide (AC), Docetaxel (D), and Alternating AC and D for Metastatic Breast Cancer

Phase 3
Completed
Conditions
Breast Cancer
Neoplasm Metastasis
First Posted Date
2005-09-19
Last Posted Date
2016-09-02
Lead Sponsor
Japan Clinical Oncology Group
Target Recruit Count
450
Registration Number
NCT00190489
Locations
🇯🇵

National Cancer Center Hospital, Chuo-ku, Tsukiji, 5-1-1, Tokyo, Japan

A Trial of Chemotherapy Before and After Surgery for Stage II,III Esophageal Squamous Cell Carcinoma

Phase 3
Terminated
Conditions
Esophageal Neoplasms
Carcinoma, Squamous Cell
First Posted Date
2005-09-19
Last Posted Date
2016-09-22
Lead Sponsor
Japan Clinical Oncology Group
Target Recruit Count
330
Registration Number
NCT00190554
Locations
🇯🇵

Aichi Cancer Center Hospital, Nagoya,Chikusa-ku,Kanokoden,1-1, Aichi, Japan

🇯🇵

Chiba University, Graduate School of Medicine, Chiba,Chuo-ku,Inohana,1-8-1, Chiba, Japan

🇯🇵

Tokyo Dental College Ichikawa General Hospital, Ichikawashi,Sugano,5-11-13, Chiba, Japan

and more 21 locations

A Trial to Evaluate Para-aortic Lymphadenectomy for Gastric Cancer

Phase 3
Completed
Conditions
Gastric Neoplasm
First Posted Date
2005-09-08
Last Posted Date
2016-09-22
Lead Sponsor
Japan Clinical Oncology Group
Target Recruit Count
520
Registration Number
NCT00149279
Locations
🇯🇵

National Cancer Center Hospital, Chuo-ku, Tokyo, Japan

A Study of 5-FU Versus MTX+5-FU in Gastric Cancer With Peritoneal Metastasis

Phase 3
Completed
Conditions
Gastric Cancer
Neoplasm Metastasis
First Posted Date
2005-09-08
Last Posted Date
2009-02-03
Lead Sponsor
Japan Clinical Oncology Group
Target Recruit Count
160
Registration Number
NCT00149201
Locations
🇯🇵

Aichi Cancer Center Hospital, 1-1,Kanokoden,Chikusa-ku,Nagoya, Aichi, Japan

🇯🇵

Aichi Cancer Center,Aichi Hospital, 18,Kuriyado,Kake-machi,Okazaki, Aichi, Japan

🇯🇵

Nagoya Medical Center, 4-1-1,Sannomaru,Naka-ku,Nagoya, Aichi, Japan

and more 31 locations
  • Prev
  • 1
  • 2
  • 3
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.